TAKEDA PHARMACEUTIC-SP ADR (TAK:NYSE)

$20.18 -0.09 (-0.444%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 54

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed TAKEDA PHARMACEUTIC-SP ADR (TAK:NYSE) News Sources

Asian Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading

22-10-2026

yahoo.com

Keros Therapeutics Eyes 2027 DMD Data as Rinvatercept Takes Center Stage

22-10-2026

marketbeat.com

2026 ESMO | Innovent Presents Multiple Clinical Data Updates for IBI363/TAK-928, a PD-1/Alpha-Biased IL-2 Bispecific Fusion Protein

26-10-2026

yahoo.com

Will Zasocitinib’s Phase 3 Outperformance Reshape Takeda Pharmaceutical's (TSE:4502) Immunology-Driven Pipeline Narrative

01-10-2026

yahoo.com

Takeda (TSE:4502) Stock Looks Below Fair Value Even After A 120% Run

01-10-2026

yahoo.com

Takeda Presents Phase 2/3 IgGNITE Study Results of Investigational Subcutaneous TAK-881 in Primary Immunodeficiency Disease (PID) at ESID 2026

14-10-2026

yahoo.com

Takeda’s ORZEYFUL (oveporexton) Launches Simultaneously in Japan and China Giving Physicians First Access to Prescribe Novel Orexin Agonist to Patients with Narcolepsy Type 1

15-10-2026

yahoo.com

Asian Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

15-10-2026

yahoo.com

Disease Clearance Data Might Change The Case For Investing In Takeda (TSE:4502)

20-10-2026

yahoo.com

Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study

23-10-2026

yahoo.com

TAKEDA PHARMACEUTIC-SP ADR (TAK:NYSE) Sentiment Trend

0 25 50 75 100 7 87 76 77 83 52 75 11 27 49 22-10-2026 26-10-2026 01-10-2026 14-10-2026 15-10-2026 20-10-2026 23-10-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

TAKEDA PHARMACEUTIC-SP ADR (TAK:NYSE) FAQs

toggle

What is the current price of TAKEDA PHARMACEUTIC-SP ADR (TAK:NYSE)?

The current price of TAKEDA PHARMACEUTIC-SP ADR (TAK:NYSE) is $20.18.


toggle

TAKEDA PHARMACEUTIC-SP ADR (TAK:NYSE) absolute price change since previous trading day?

The absolute price change of TAKEDA PHARMACEUTIC-SP ADR (TAK:NYSE) since the previous trading day is $-0.09.


toggle

TAKEDA PHARMACEUTIC-SP ADR (TAK:NYSE) percentage price change since previous trading day?

The percentage price change of TAKEDA PHARMACEUTIC-SP ADR (TAK:NYSE) since the previous trading day is -0.444%.


toggle

What is the most recent average sentiment score for TAKEDA PHARMACEUTIC-SP ADR (TAK:NYSE)?

The most recent average sentiment score for TAKEDA PHARMACEUTIC-SP ADR (TAK:NYSE) is 54 out of 100.


toggle

What is the most recent average sentiment for TAKEDA PHARMACEUTIC-SP ADR (TAK:NYSE)?

The most recent sentiment for TAKEDA PHARMACEUTIC-SP ADR (TAK:NYSE) is .


SEC-8K** Filing Available For TAKEDA PHARMACEUTIC-SP ADR (TAK:NYSE)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.